281 related articles for article (PubMed ID: 23226202)
1. Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation.
Bielekova B; Komori M; Xu Q; Reich DS; Wu T
PLoS One; 2012; 7(11):e48370. PubMed ID: 23226202
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
Komori M; Blake A; Greenwood M; Lin YC; Kosa P; Ghazali D; Winokur P; Natrajan M; Wuest SC; Romm E; Panackal AA; Williamson PR; Wu T; Bielekova B
Ann Neurol; 2015 Jul; 78(1):3-20. PubMed ID: 25808056
[TBL] [Abstract][Full Text] [Related]
3. Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities.
Levraut M; Landes C; Mondot L; Cohen M; Bresch S; Brglez V; Seitz-Polski B; Lebrun-Frenay C
Front Immunol; 2022; 13():864133. PubMed ID: 35401550
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of the C-X-C motif chemokine ligand 13 and interleukin-8 in predicting the transition from clinically isolated syndrome to multiple sclerosis.
Klíčová K; Mareš J; Sobek O; Rous Z; Rous M; Raška M; Hartung HP
Eur J Neurosci; 2024 Jun; 59(11):2955-2966. PubMed ID: 38453679
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
[TBL] [Abstract][Full Text] [Related]
6. Discriminating between Lyme neuroborreliosis and other central nervous system infections by use of biomarkers CXCL13 and IL-6.
Leth TA; Dessau RB; Møller JK
Ticks Tick Borne Dis; 2022 Sep; 13(5):101984. PubMed ID: 35709639
[TBL] [Abstract][Full Text] [Related]
7. Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers.
Liba Z; Nohejlova H; Capek V; Krsek P; Sediva A; Kayserova J
PLoS One; 2019; 14(7):e0219987. PubMed ID: 31356620
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.
Ferraro D; Galli V; Vitetta F; Simone AM; Bedin R; Del Giovane C; Morselli F; Filippini MM; Nichelli PF; Sola P
J Neuroimmunol; 2015 Jun; 283():64-9. PubMed ID: 26004159
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N
J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557
[TBL] [Abstract][Full Text] [Related]
10. BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.
Puthenparampil M; Federle L; Miante S; Zito A; Toffanin E; Ruggero S; Ermani M; Pravato S; Poggiali D; Perini P; Rinaldi F; Gallo P
J Neuroinflammation; 2017 Jan; 14(1):11. PubMed ID: 28095856
[TBL] [Abstract][Full Text] [Related]
11. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland A
J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
[TBL] [Abstract][Full Text] [Related]
12. The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF.
Harrer C; Otto F; Pilz G; Haschke-Becher E; Trinka E; Hitzl W; Wipfler P; Harrer A
Fluids Barriers CNS; 2021 Aug; 18(1):40. PubMed ID: 34446066
[TBL] [Abstract][Full Text] [Related]
13. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.
Hytönen J; Kortela E; Waris M; Puustinen J; Salo J; Oksi J
J Neuroinflammation; 2014 Jun; 11():103. PubMed ID: 24920219
[TBL] [Abstract][Full Text] [Related]
14. The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).
Brettschneider J; Czerwoniak A; Senel M; Fang L; Kassubek J; Pinkhardt E; Lauda F; Kapfer T; Jesse S; Lehmensiek V; Ludolph AC; Otto M; Tumani H
PLoS One; 2010 Aug; 5(8):e11986. PubMed ID: 20700489
[TBL] [Abstract][Full Text] [Related]
15. CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.
Kowarik MC; Cepok S; Sellner J; Grummel V; Weber MS; Korn T; Berthele A; Hemmer B
J Neuroinflammation; 2012 May; 9():93. PubMed ID: 22591862
[TBL] [Abstract][Full Text] [Related]
16. Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.
Khademi M; Dring AM; Gilthorpe JD; Wuolikainen A; Al Nimer F; Harris RA; Andersson M; Brundin L; Piehl F; Olsson T; Svenningsson A
PLoS One; 2013; 8(5):e63172. PubMed ID: 23667585
[TBL] [Abstract][Full Text] [Related]
17. Highly sensitive quantification of optic neuritis intrathecal biomarker CXCL13.
Olesen MN; Nilsson AC; Pihl-Jensen G; Soelberg KK; Olsen DA; Brandslund I; Lillevang ST; Madsen JS; Frederiksen JL; Asgari N
Mult Scler Relat Disord; 2020 Sep; 44():102281. PubMed ID: 32570180
[TBL] [Abstract][Full Text] [Related]
18. CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients.
Wang C; Wu K; Yu Q; Zhang S; Gao Z; Liu Y; Ni L; Cheng Y; Guan Z; Shi M; Lu H; Lou Y; Zhou P
Sci Rep; 2016 Sep; 6():33569. PubMed ID: 27650493
[TBL] [Abstract][Full Text] [Related]
19. CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis.
Lucchini M; De Arcangelis V; Piro G; Nociti V; Bianco A; De Fino C; Di Sante G; Ria F; Calabresi P; Mirabella M
Mol Neurobiol; 2023 Jan; 60(1):36-50. PubMed ID: 36215027
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis.
Rupprecht TA; Manz KM; Fingerle V; Lechner C; Klein M; Pfirrmann M; Koedel U
Clin Microbiol Infect; 2018 Dec; 24(12):1234-1240. PubMed ID: 29674128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
